Global Cholesterol Testing Market to Reach $31.7 Billion by 2030
The global market for Cholesterol Testing estimated at US$22 Billion in the year 2022, is projected to reach a revised size of US$31.7 Billion by 2030, growing at a CAGR of 4.7% over the analysis period 2022-2030. Diagnostic Centers, one of the segments analyzed in the report, is projected to record a 5.9% CAGR and reach US$11.6 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Physicians / Providers & Hospitals segment is readjusted to a revised 4.6% CAGR for the next 8-year period.The U.S. Market is Estimated at $6.4 Billion, While China is Forecast to Grow at 8% CAGR
The Cholesterol Testing market in the U.S. is estimated at US$6.4 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$5.9 Billion by the year 2030 trailing a CAGR of 8% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 1.6% and 5.3% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 2.5% CAGR. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$4.4 Billion by the year 2030.Select Competitors (Total 42 Featured) -
- Abbott Laboratories
- AccuTech LLC
- Akers Biosciences Inc.
- Beckman Coulter Inc.
- Bio-Rad Laboratories Inc.
- Boston Heart Diagnostics Corporation
- Eurofins Scientific
- F. Hoffmann-La Roche Ltd.
- Home Access Health Corporation
- Laboratory Corporation of America® Holdings
- PTS Diagnostics
- Quest Diagnostics Inc.
- Randox Laboratories Ltd.
- Sekisui Diagnostics LLC
- Siemens Healthineers
- Sigma-Aldrich Corp.
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
Table of Contents
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Laboratories
- AccuTech LLC
- Akers Biosciences Inc.
- Beckman Coulter Inc.
- Bio-Rad Laboratories Inc.
- Boston Heart Diagnostics Corporation
- Eurofins Scientific
- F. Hoffmann-La Roche Ltd.
- Home Access Health Corporation
- Laboratory Corporation of America® Holdings
- PTS Diagnostics
- Quest Diagnostics Inc.
- Randox Laboratories Ltd.
- Sekisui Diagnostics LLC
- Siemens Healthineers
- Sigma-Aldrich Corp.
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 273 |
Published | May 2024 |
Forecast Period | 2022 - 2030 |
Estimated Market Value ( USD | $ 22 Billion |
Forecasted Market Value ( USD | $ 31.7 Billion |
Compound Annual Growth Rate | 4.7% |
Regions Covered | Global |